Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thoughtonomy is a technology company that developed an intelligent automation platform designed to provide a "Virtual Workforce" for enterprises. The company's software combines robotic process automation (RPA) with artificial intelligence and machine learning to automate complex, end-to-end business processes. In the healthcare sector, Thoughtonomy gained significant traction through its work with the UK's National Health Service (NHS), where its platform was used to automate administrative tasks such as GP referrals, patient scheduling, and data entry. Thoughtonomy was acquired by Blue Prism in 2019 for approximately $100 million and is now part of the SS&C Blue Prism business unit within SS&C Technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thoughtonomy.